Search results for " market"
Article
Monoclonal Antibodies Key to Unlocking the Biosimilars Market
Development of clear, regulatory approval pathways for biosimilars in emerging markets is creating large, additional opportunities for biosimilar mAbs. Education of physicians, pharmacists, and patien…
Article
Moving Biosimilars Forward in a Hesitant Market
Still, Gabrielson notes that the US lags roughly 10 years behind Europe in marketing biosimilars, with the first biosimilar, Zarxio (filgrastim-sndz), approved in the US in 2015 (1). “We’re looking at…
Article
Navigating Emerging Markets: Middle East and North Africa
Middle East Health and Pharmaceutical Market Overview
Many consider the Middle East to be a group of closely related, culturally uniform states with relatively similar forms of governance and le…
Article
Biopharmaceutical Market in Asia: Q&A with Günter Jagschies, Strategic Customer Relations Leader, Cytiva
However, the Asian market is not a fully homogeneous market. What is your perception, and what is the current state in the respective areas/countries?
Indeed, I would agree that the situation in v…
Article
Accelerating time to market through process innovation
During this workshop you will hear from industry experts from Cytiva, Chugai Pharmaceuticals and NorthX Biologics on process innovations to accelerate your time to market.
Topics include:
- Next…
Webcast
Accelerating time to market through process innovation
During this workshop you we hear from industry experts from Cytiva and NorthX Biologics on process innovations to accelerate your time to market.
Topics include:
- Developing and scaling up a …
Article
Emerging biopharma: progressing a biologic drug to market
There are many pitfalls in the road to developing and bringing a new therapy to market. Understanding some of these areas and being prepared to make the right decisions at the right ti…
Article
Increasing mRNA Capabilities and Capacity for Growing Market Needs
Click here to read more >>
The success of the mRNA vaccine market is fueling high demand for mRNA, resulting in a critical need to address the manufacturing bottlenecks.
Article
Manage HCPs and Enhance Your Route to Market
Learn how the right HCP strategy can enhance your route to market.
Article
Manage HCPs and Enhance Your Route to Market
Learn how the right HCP strategy can enhance your route to market.